Cargando…

[N,N-Bis(2-pyridylmeth­yl)glycinato-κ(4) N,N′,N′′,O]dichloridoiron(III)–[N,N-bis­(2-pyridylmeth­yl)glycine-κ(4) N,N′,N′′,O]dichloridozinc(II) (1/1)

The title compound, [Fe(C(14)H(14)N(3)O(2))Cl(2)]·[ZnCl(2)(C(14)H(15)N(3)O(2))], is formulated as [Fe(III)(bpg)Cl(2)][Zn(II)Cl(2)(bpgH)], where bpg is the tetra­dentate ligand N,N-bis­(2-pyridylmeth­yl)glycine. The structure contains one crystallographically distinct complex with Fe(III) and Zn(II)...

Descripción completa

Detalles Bibliográficos
Autores principales: Nielsen, Anne, McKenzie, Christine J., Bond, Andrew D.
Formato: Texto
Lenguaje:English
Publicado: International Union of Crystallography 2009
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2972039/
https://www.ncbi.nlm.nih.gov/pubmed/21578707
http://dx.doi.org/10.1107/S1600536809051022
_version_ 1782190729707126784
author Nielsen, Anne
McKenzie, Christine J.
Bond, Andrew D.
author_facet Nielsen, Anne
McKenzie, Christine J.
Bond, Andrew D.
author_sort Nielsen, Anne
collection PubMed
description The title compound, [Fe(C(14)H(14)N(3)O(2))Cl(2)]·[ZnCl(2)(C(14)H(15)N(3)O(2))], is formulated as [Fe(III)(bpg)Cl(2)][Zn(II)Cl(2)(bpgH)], where bpg is the tetra­dentate ligand N,N-bis­(2-pyridylmeth­yl)glycine. The structure contains one crystallographically distinct complex with Fe(III) and Zn(II) atoms present in a 50:50 ratio in a single-atom site. The non-coordinated O atoms of the carboxyl groups of bpg meet across crystallographic inversion centres, forming O—H⋯O hydrogen bonds that include only one H atom per two complexes, consistent with the 1:1 disorder of Fe(III) and Zn(II).
format Text
id pubmed-2972039
institution National Center for Biotechnology Information
language English
publishDate 2009
publisher International Union of Crystallography
record_format MEDLINE/PubMed
spelling pubmed-29720392010-12-30 [N,N-Bis(2-pyridylmeth­yl)glycinato-κ(4) N,N′,N′′,O]dichloridoiron(III)–[N,N-bis­(2-pyridylmeth­yl)glycine-κ(4) N,N′,N′′,O]dichloridozinc(II) (1/1) Nielsen, Anne McKenzie, Christine J. Bond, Andrew D. Acta Crystallogr Sect E Struct Rep Online Metal-Organic Papers The title compound, [Fe(C(14)H(14)N(3)O(2))Cl(2)]·[ZnCl(2)(C(14)H(15)N(3)O(2))], is formulated as [Fe(III)(bpg)Cl(2)][Zn(II)Cl(2)(bpgH)], where bpg is the tetra­dentate ligand N,N-bis­(2-pyridylmeth­yl)glycine. The structure contains one crystallographically distinct complex with Fe(III) and Zn(II) atoms present in a 50:50 ratio in a single-atom site. The non-coordinated O atoms of the carboxyl groups of bpg meet across crystallographic inversion centres, forming O—H⋯O hydrogen bonds that include only one H atom per two complexes, consistent with the 1:1 disorder of Fe(III) and Zn(II). International Union of Crystallography 2009-11-28 /pmc/articles/PMC2972039/ /pubmed/21578707 http://dx.doi.org/10.1107/S1600536809051022 Text en © Nielsen et al. 2009 http://creativecommons.org/licenses/by/2.0/uk/ This is an open-access article distributed under the terms of the Creative Commons Attribution Licence, which permits unrestricted use, distribution, and reproduction in any medium, provided the original authors and source are cited.
spellingShingle Metal-Organic Papers
Nielsen, Anne
McKenzie, Christine J.
Bond, Andrew D.
[N,N-Bis(2-pyridylmeth­yl)glycinato-κ(4) N,N′,N′′,O]dichloridoiron(III)–[N,N-bis­(2-pyridylmeth­yl)glycine-κ(4) N,N′,N′′,O]dichloridozinc(II) (1/1)
title [N,N-Bis(2-pyridylmeth­yl)glycinato-κ(4) N,N′,N′′,O]dichloridoiron(III)–[N,N-bis­(2-pyridylmeth­yl)glycine-κ(4) N,N′,N′′,O]dichloridozinc(II) (1/1)
title_full [N,N-Bis(2-pyridylmeth­yl)glycinato-κ(4) N,N′,N′′,O]dichloridoiron(III)–[N,N-bis­(2-pyridylmeth­yl)glycine-κ(4) N,N′,N′′,O]dichloridozinc(II) (1/1)
title_fullStr [N,N-Bis(2-pyridylmeth­yl)glycinato-κ(4) N,N′,N′′,O]dichloridoiron(III)–[N,N-bis­(2-pyridylmeth­yl)glycine-κ(4) N,N′,N′′,O]dichloridozinc(II) (1/1)
title_full_unstemmed [N,N-Bis(2-pyridylmeth­yl)glycinato-κ(4) N,N′,N′′,O]dichloridoiron(III)–[N,N-bis­(2-pyridylmeth­yl)glycine-κ(4) N,N′,N′′,O]dichloridozinc(II) (1/1)
title_short [N,N-Bis(2-pyridylmeth­yl)glycinato-κ(4) N,N′,N′′,O]dichloridoiron(III)–[N,N-bis­(2-pyridylmeth­yl)glycine-κ(4) N,N′,N′′,O]dichloridozinc(II) (1/1)
title_sort [n,n-bis(2-pyridylmeth­yl)glycinato-κ(4) n,n′,n′′,o]dichloridoiron(iii)–[n,n-bis­(2-pyridylmeth­yl)glycine-κ(4) n,n′,n′′,o]dichloridozinc(ii) (1/1)
topic Metal-Organic Papers
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2972039/
https://www.ncbi.nlm.nih.gov/pubmed/21578707
http://dx.doi.org/10.1107/S1600536809051022
work_keys_str_mv AT nielsenanne nnbis2pyridylmethylglycinatok4nnnodichloridoironiiinnbis2pyridylmethylglycinek4nnnodichloridozincii11
AT mckenziechristinej nnbis2pyridylmethylglycinatok4nnnodichloridoironiiinnbis2pyridylmethylglycinek4nnnodichloridozincii11
AT bondandrewd nnbis2pyridylmethylglycinatok4nnnodichloridoironiiinnbis2pyridylmethylglycinek4nnnodichloridozincii11